Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saffron extract is a concentrated preparation derived from the dried stigmas of the Crocus sativus L. flower. It contains several bioactive compounds including crocin (responsible for color), picrocrocin (taste), and safranal (aroma), as well as flavonoids like kaempferol and quercetin[6][8][10]. Saffron has been used traditionally for its sedative, antidepressant, anti-inflammatory, antioxidant, and potential anticancer properties[2][5]. Its mechanism of action is thought to involve modulation of neurotransmitters such as serotonin in the brain and antioxidant activity that protects cells from oxidative stress[1][5]. Clinical studies suggest possible efficacy in mild to moderate depression and Alzheimer’s disease symptoms; however, evidence for other uses remains limited or preliminary[1][2][3]. Saffron extract is most commonly administered orally in doses ranging from 20–100 mg daily for up to 26 weeks[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saffron extract.